Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors
Abstract:Aminopeptidases play essential roles in protein maturation, activation, and stability as well as in the degradation and regulation of hormonal and nonhormonal peptides that can serve as important enzyme targets for drug design. This review will focus on an effective inhibitor of aminopeptidases, bestatin, including work to find better inhibitors in the past three decades that has sought to optimize bestatin and prospective developments in bestatin optimization in the future.
Keywords: Aminopeptidases; Enzymes; aminopeptidases; analogues; bestatin; hydrolysis; hypertension; inflammation; leukemias; neurodegeneration; nonhormonal peptides; optimization; pathological disorders
Document Type: Research Article
Publication date: March 1, 2011
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.